Seres Therapeutics Inc MCRB
NASDAQ · United States · Health Technology
$2.94+0.01 (+0.34%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-05 | 0.47 | -2.19 | +121.5% | $736.00K | +311.2% | -8.2%$5.25→$4.82 |
| Q1 2026 | 2026-05-05 | -2.08 | — | — | — | — | +4.0%$7.69→$8.00 |
| Q4 2025 | 2026-03-12 | -1.76 | -1.60 | -10.0% | — | — | -3.4%$8.93→$8.63 |
| Q3 2025 | 2025-11-05 | 0.94 | 0.05 | +1,780.0% | — | — | +0.8%$13.75→$13.86 |
| Q4 2024 | 2025-03-13 | -2.20 | -3.99 | +44.9% | — | — | — |
| Q3 2024 | 2024-11-13 | -6.60 | -0.04 | -16,400.0% | — | — | — |
| Q2 2024 | 2024-08-13 | -4.40 | -5.91 | +25.5% | — | — | — |
| Q4 2023 | 2024-03-05 | -5.53 | -11.36 | +51.3% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.